NanoBio raises $22 million as partnering plans near fruition
This article was originally published in Scrip
Executive Summary
NanoBio has closed a $22 million series B financing round after Perseus, its majority shareholder, and Venture Investors committed an additional $10 million. A first close of $12 million was announced in February.